Literature DB >> 19218299

The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis.

Erin M Snook1, Robert W Motl, Rachael C Gliottoni.   

Abstract

OBJECTIVE: To examine whether accelerometry provides a measure of physical activity, walking ability or both in a sample of individuals with multiple sclerosis. The secondary purpose was to examine the validity of physical activity measures in people with multiple sclerosis who have ambulatory impairments. PARTICIPANTS: Forty-two individuals with multiple sclerosis without ambulatory impairment (Expanded Disability Status Scale (EDSS) score < or = 4.5) and 32 individuals with multiple sclerosis with ambulatory impairment (EDSS > or = 5.0).
METHOD: Participants completed the Multiple Sclerosis Walking Scale-12 and Performance Scales, wore an accelerometer for seven days, and completed the Godin Leisure-Time Exercise Questionnaire and short-form of the International Physical Activity Questionnaire.
RESULTS: There were significant differences between groups on scores from the five measures. There were large correlations between the accelerometer counts with scores from both the self-report measures of physical activity and the self-report measures of walking mobility in the overall sample. There were large correlations between scores from both measures of physical activity in the overall sample and the subsample with ambulatory impairment.
CONCLUSION: Our data suggest that accelerometers are measuring both physical activity and walking mobility in individuals with multiple sclerosis, whereas self-report measures are measuring physical activity in individuals with multiple sclerosis, including those with ambulatory impairment.

Entities:  

Mesh:

Year:  2009        PMID: 19218299     DOI: 10.1177/0269215508101757

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  16 in total

1.  Does a waist-worn accelerometer capture intra- and inter-person variation in walking behavior among persons with multiple sclerosis?

Authors:  Robert W Motl; Jacob J Sosnoff; Deirdre Dlugonski; Yoojin Suh; Myla Goldman
Journal:  Med Eng Phys       Date:  2010-09-26       Impact factor: 2.242

2.  ADSTEP: Preliminary Investigation of a Multicomponent Walking Aid Program in People With Multiple Sclerosis.

Authors:  Douglas N Martini; Eline Zeeboer; Andrea Hildebrand; Brett W Fling; Cinda L Hugos; Michelle H Cameron
Journal:  Arch Phys Med Rehabil       Date:  2018-06-26       Impact factor: 3.966

3.  Quantity and quality of gait and turning in people with multiple sclerosis, Parkinson's disease and matched controls during daily living.

Authors:  Vrutangkumar V Shah; James McNames; Martina Mancini; Patricia Carlson-Kuhta; Rebecca I Spain; John G Nutt; Mahmoud El-Gohary; Carolin Curtze; Fay B Horak
Journal:  J Neurol       Date:  2020-01-11       Impact factor: 4.849

4.  Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.

Authors:  Myla D Goldman; Robert W Motl; Richard A Rudick
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

5.  Accelerometry and its association with objective markers of walking limitations in ambulatory adults with multiple sclerosis.

Authors:  Robert W Motl; Deirdre Dlugonski; Yoojin Suh; Madeline Weikert; Bo Fernhall; Myla Goldman
Journal:  Arch Phys Med Rehabil       Date:  2010-12       Impact factor: 3.966

6.  Treatment of walking impairment in multiple sclerosis with dalfampridine.

Authors:  Andrew R Blight
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

7.  Digital Phenotyping in Clinical Neurology.

Authors:  Anoopum S Gupta
Journal:  Semin Neurol       Date:  2022-01-11       Impact factor: 3.212

8.  Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis.

Authors:  Brian M Sandroff; Rachel E Klaren; Lara A Pilutti; Deirdre Dlugonski; Ralph H B Benedict; Robert W Motl
Journal:  J Neurol       Date:  2013-12-10       Impact factor: 4.849

9.  Serum Histidine is Lower in Fatigued Women with Multiple Sclerosis.

Authors:  Bryan D Loy; Brett W Fling; Kylie M Sage; Rebecca I Spain; Fay B Horak
Journal:  Fatigue       Date:  2019-05-07

10.  Free-Living Physical Activity Monitoring in Adult US Patients with Multiple Sclerosis Using a Consumer Wearable Device.

Authors:  Pronabesh DasMahapatra; Emil Chiauzzi; Rishi Bhalerao; Jane Rhodes
Journal:  Digit Biomark       Date:  2018-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.